Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1) | MicrobiomeTrials← Back to trialsNCT05652504
Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)
SUSPENDEDPHASE1INTERVENTIONAL
Trial Details
Start: 2026-06-14Est. Completion: 2026-11-30
Enrollment target: 400 participants Locations- Ou(SqrRoot)(Copyright)less(SqrRoot)(Copyright)bougou, Health Research Center, Ou(SqrRoot)(Copyright)less(SqrRoot)(Copyright)bougou, Mali
Other microbiome trials you might be interested in
Plasmodium Vivax MalariaMalaria
FLAME is an open-label cluster-randomized controlled trial that aims to determine the effectiveness of focal mass drug a…
Iquitos, PeruEst. completion May 1, 2027
Malaria
The MIC-DroP trial will test the hypothesis that preventing early life blood-stage malaria antigenic exposure with inter…
Tororo, UgandaEst. completion May 5, 2027